Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satavaptan in SIADH
NCT00728091Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Jul 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of satavaptan in syndrome of inappropriate antidiuretic hormone secretion (SIADH), hyponatremia, sponsored by Sanofi. Started Jul 2008; status: terminated.
02
Drugs
satavaptan
03
Conditions
syndrome of inappropriate antidiuretic hormone secretion (SIADH)hyponatremia
Beyond the preview
Go deeper on NCT00728091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728091.